The overall ratings of ten Medical Devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Delcath Systems (NASDAQ:DCTH) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Delcath Systems operates as a specialty pharmaceutical and medical device company. In Portfolio Grader’s specific subcategories of Equity and Cash Flow, DCTH also gets F’s. The stock price has fallen 15.4% over the past month, worse than the 5.5% increase the Nasdaq has seen over the same period of time. As of Sept. 17, 11% of outstanding Delcath Systems shares were held short. For a full analysis of DCTH stock, visit Portfolio Grader.
Synergetics USA‘s (NASDAQ:SURG) rating falls to a D (“sell”) this week, down from C (“hold”) the week prior. Synergetics USA develops and manufactures medical devices and products for the hospital and healthcare communities. The stock gets F’s in Earnings Momentum and Earnings Surprise. To get an in-depth look at SURG, get Portfolio Grader’s complete analysis of SURG stock.
This is a rough week for Merit Medical Systems (NASDAQ:MMSI). The company’s rating falls to D from the previous week’s C. Merit Medical Systems is engaged in the development, manufacture, and marketing of disposable medical products that are used primarily in diagnostic and interventional cardiology and radiology procedures. The stock also gets an F in Earnings Momentum. The stock’s trailing PE Ratio is 30.2. For more information, get Portfolio Grader’s complete analysis of MMSI stock.
The rating of Hill-Rom Holdings (NYSE:HRC) declines this week from a C to a D. Hill-Rom Holdings manufactures equipment for the healthcare industry, and provides wound care and pulmonary/trauma management services. For a full analysis of HRC stock, visit Portfolio Grader.
Palomar Medical Technologies (NASDAQ:PMTI) earns a D this week, moving down from last week’s grade of C. Palomar Medical Technologies develops and supplies proprietary laser systems for hair removal and other cosmetic laser treatments. The stock gets F’s in Earnings Momentum and Equity. Share prices fell 4.7% over the past month. For more information, get Portfolio Grader’s complete analysis of PMTI stock.
This week, Volcano‘s (NASDAQ:VOLC) rating worsens to a D from the company’s C rating a week ago. Volcano designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. The stock also rates an F in Earnings Momentum. The stock currently has a trailing PE Ratio of 42.3. The price of VOLC dropped 1% from the month prior. To get an in-depth look at VOLC, get Portfolio Grader’s complete analysis of VOLC stock.
Hansen Medical (NASDAQ:HNSN) earns an F this week, falling from last week’s grade of D. Hansen Medical develops and manufactures medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The stock receives F’s in Earnings Growth, Earnings Momentum, and Equity. Cash Flow and Sales Growth also get F’s. As of Sept. 17, 15.5% of outstanding Hansen Medical shares were held short. For a full analysis of HNSN stock, visit Portfolio Grader.
NxStage Medical (NASDAQ:NXTM) is having a tough week. The company’s rating falls from a D to an F rating. NxStage Medical is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease and acute kidney failure. The stock also gets an F in Equity. As of Sept. 17, 10.6% of outstanding NxStage Medical shares were held short. The price of NXTM fell 1.6% from a month ago. For more information, get Portfolio Grader’s complete analysis of NXTM stock.
Cutera (NASDAQ:CUTR) experiences a ratings drop this week, going from last week’s C to a D. Cutera is a global provider of laser and other light-based aesthetic systems for practitioners worldwide. The stock gets F’s in Equity and Cash Flow. To get an in-depth look at CUTR, get Portfolio Grader’s complete analysis of CUTR stock.
Alphatec Holdings‘s (NASDAQ:ATEC) rating weakens this week, dropping to an F versus last week’s D. Alphatec Holdings designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, primarily focusing on the aging spine in the United States and internationally. The stock gets F’s in Earnings Revisions, Equity, and Cash Flow. For a full analysis of ATEC stock, visit Portfolio Grader.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.